Cover Image
市場調查報告書

學名藥:全球的產業指南

Generics Global Industry Guide 2017-2021

出版商 MarketLine 商品編碼 251357
出版日期 內容資訊 英文 247 Pages
訂單完成後即時交付
價格
Back to Top
學名藥:全球的產業指南 Generics Global Industry Guide 2017-2021
出版日期: 2018年02月28日 內容資訊: 英文 247 Pages
簡介

本報告提供全球、各地區及主要國家學名藥市場相關資料,市場規模及區隔相關詳細資料,以及主要趨勢和競爭情形分析,並提供主要企業簡介等,為您概述為以下內容。

摘要整理

  • 市場銷售額
  • 市場銷售額的預測
  • 市場交易數量
  • 市場交易數量的預測
  • 地區區分

簡介

  • 關於本報告
  • 主要讀者
  • 該報告的利用方法
  • 定義

全球學名藥市場

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析

學名藥市場:亞太地區

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析

學名藥市場:歐洲

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析

學名藥市場:法國

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:德國

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:義大利

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:日本

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:比利時

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:加拿大

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:中國

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:荷蘭

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:西班牙

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:英國

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

學名藥市場:美國

  • 市場概要
  • 市場資料
  • 市場區分
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標
  • 企業簡介
  • 主要企業

附錄

  • 調查手法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MLIG1744-06

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The market value is evaluated at ex-factory prices.

Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

All currency conversions were calculated at constant average annual 2016 exchange rates.

The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.

Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.

Strong growth will continue in the emerging markets but worldwide there will be a deceleration.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
  • Reasons to buy
  • What was the size of the global generics market by value in 2016?
  • What will be the size of the global generics market in 2021?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?

Table of Contents

EXECUTIVE SUMMARY 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Geography segmentation 2

Introduction 19

What is this report about? 19

Who is the target reader? 19

How to use this report 19

Definitions 19

Global Generics 20

Market Overview 20

Market Data 21

Market Segmentation 23

Market outlook 24

Five forces analysis 26

Generics in Asia-Pacific 32

Market Overview 32

Market Data 33

Market Segmentation 35

Market outlook 36

Five forces analysis 38

Generics in Europe 44

Market Overview 44

Market Data 45

Market Segmentation 47

Market outlook 48

Five forces analysis 50

Generics in France 56

Market Overview 56

Market Data 57

Market Segmentation 59

Market outlook 60

Five forces analysis 62

Macroeconomic indicators 68

Generics in Germany 70

Market Overview 70

Market Data 71

Market Segmentation 73

Market outlook 74

Five forces analysis 76

Macroeconomic indicators 82

Generics in Italy 84

Market Overview 84

Market Data 85

Market Segmentation 87

Market outlook 88

Five forces analysis 90

Macroeconomic indicators 96

Generics in Japan 98

Market Overview 98

Market Data 99

Market Segmentation 101

Market outlook 102

Five forces analysis 104

Macroeconomic indicators 110

Generics in Australia 112

Market Overview 112

Market Data 113

Market Segmentation 115

Market outlook 116

Five forces analysis 118

Macroeconomic indicators 124

Generics in Canada 126

Market Overview 126

Market Data 127

Market Segmentation 129

Market outlook 130

Five forces analysis 132

Macroeconomic indicators 138

Generics in China 140

Market Overview 140

Market Data 141

Market Segmentation 143

Market outlook 144

Five forces analysis 146

Macroeconomic indicators 153

Generics in The Netherlands 155

Market Overview 155

Market Data 156

Market Segmentation 158

Market outlook 159

Five forces analysis 161

Macroeconomic indicators 167

Generics in Spain 169

Market Overview 169

Market Data 170

Market Segmentation 172

Market outlook 173

Five forces analysis 175

Macroeconomic indicators 181

Generics in The United Kingdom 183

Market Overview 183

Market Data 184

Market Segmentation 186

Market outlook 187

Five forces analysis 189

Macroeconomic indicators 195

Generics in The United States 197

Market Overview 197

Market Data 198

Market Segmentation 200

Market outlook 201

Five forces analysis 203

Macroeconomic indicators 209

Company Profiles 211

Leading Companies 211

Appendix 245

Methodology 245

About MarketLine 246

Back to Top